RPID
Rapid Micro Biosystems, Inc. NASDAQ Listed Jul 15, 2021$1.69
Mkt Cap $75.5M
52w Low $1.66
1.0% of range
52w High $4.68
50d MA $2.14
200d MA $3.12
P/E (TTM)
-1.5x
EV/EBITDA
—
P/B
2.3x
Debt/Equity
0.7x
ROE
-141.9%
P/FCF
-2.4x
RSI (14)
24.50
ATR (14)
$0.12
Beta
1.60
50d MA
$2.14
200d MA
$3.12
Avg Volume
167.3K
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
1001 Pawtucket Boulevard West · Lowell, MA 01854 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | AMC | -0.23 | -0.28 | -21.7% | 3.43 | +3.2% | -17.5% | +4.9% | -1.7% | -8.2% | -6.7% | — |
| Nov 7, 2025 | AMC | -0.26 | -0.26 | +0.0% | 3.10 | +1.0% | +4.5% | +16.0% | +10.1% | +7.7% | -5.6% | — |
| Aug 12, 2025 | AMC | -0.26 | -0.27 | -3.8% | 2.68 | -3.0% | +8.6% | -3.1% | -7.1% | +1.1% | -7.2% | — |
| May 9, 2025 | AMC | -0.27 | -0.26 | +3.7% | 3.08 | -2.6% | -5.2% | +8.2% | -5.1% | +2.0% | +4.9% | — |
| Feb 28, 2025 | AMC | -0.22 | -0.22 | +0.0% | 3.05 | -3.6% | -15.1% | -4.6% | +10.1% | -3.7% | -8.8% | — |
| Nov 1, 2024 | AMC | -0.26 | -0.26 | +0.0% | 1.10 | -0.9% | -1.8% | +0.9% | +4.6% | +8.8% | +1.6% | — |
| Aug 2, 2024 | AMC | -0.28 | -0.29 | -3.6% | 0.80 | -0.6% | -0.8% | -1.0% | -4.0% | +13.4% | -0.0% | — |
| May 3, 2024 | AMC | -0.29 | -0.31 | -6.9% | 0.89 | +3.3% | -1.5% | -1.9% | -7.4% | +1.0% | -0.6% | — |
| Mar 1, 2024 | AMC | -0.31 | -0.26 | +16.1% | 0.98 | +4.1% | +1.0% | +0.0% | +1.0% | -2.1% | +0.2% | — |
| Nov 3, 2023 | AMC | -0.32 | -0.31 | +3.1% | 1.09 | +5.5% | -3.7% | -3.8% | +1.0% | -3.4% | -1.3% | — |
| Aug 4, 2023 | AMC | -0.36 | -0.33 | +8.3% | 0.92 | +2.2% | -2.2% | +1.1% | -2.2% | +5.5% | -1.2% | — |
| May 5, 2023 | AMC | -0.36 | -0.32 | +11.1% | 0.89 | +0.0% | -6.7% | +6.0% | +0.0% | +0.0% | +2.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $1.28 | $1.26 | -1.6% | +9.4% | -9.3% | -2.4% | -6.5% | -5.2% |
| Aug 16 | JP Morgan | Downgrade | Overweight → Neutral | — | $3.83 | $3.69 | -3.7% | -8.6% | +1.7% | -7.3% | -8.2% | -2.6% |
| May 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.46 | $4.35 | -2.5% | -12.8% | -3.3% | +6.4% | -4.5% | +11.3% |
| Mar 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.76 | $5.73 | -0.5% | +0.2% | +4.2% | +12.6% | -7.2% | -0.2% |
| Feb 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.31 | $7.47 | +2.2% | +7.0% | -0.1% | -9.9% | +2.0% | -1.7% |
| Nov 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.23 | $17.24 | +0.1% | -4.5% | +1.2% | -1.1% | -1.3% | -1.6% |
| Aug 9 | JP Morgan | Maintains | Overweight → Overweight | — | $23.35 | $23.02 | -1.4% | -4.5% | -3.1% | +0.1% | -14.7% | +2.8% |
| Aug 9 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $23.35 | $23.02 | -1.4% | -4.5% | -3.1% | +0.1% | -14.7% | +2.8% |
| Aug 9 | Stifel | Maintains | Buy → Buy | — | $23.35 | $23.02 | -1.4% | -4.5% | -3.1% | +0.1% | -14.7% | +2.8% |
| Aug 9 | TD Cowen | Maintains | Outperform → Outperform | — | $23.35 | $23.02 | -1.4% | -4.5% | -3.1% | +0.1% | -14.7% | +2.8% |
No insider trades available.
8-K
Rapid Micro Biosystems, Inc. -- 8-K Filing
I cannot provide a meaningful analysis based on this summary, as it contains only standard SEC filing boilerplate language without substantive information about a material event or transaction affecting Rapid Micro Biosystems investors.
May 28
8-K · 1.01
!! High
Rapid Micro Biosystems, Inc. -- 8-K 1.01: Material Agreement
Rapid Micro Biosystems is executing an underwritten public offering expected to close May 20, 2026, providing capital through a structured equity or debt issuance.
May 19
8-K · 2.02
!! High
Rapid Micro Biosystems, Inc. -- 8-K 2.02: Earnings Results
Rapid Micro Biosystems reported earnings results in an 8-K filing, with detailed financial performance disclosed in an attached press release for investor review.
May 13
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
RPID's departing executive transitions to a consultant role at $200/hour, suggesting a managed transition that may signal leadership instability or planned strategic shift requiring continued guidance.
Mar 27
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
RPID's 20% YoY revenue growth demonstrates strong market demand for its automation solutions, signaling healthy business momentum that could support stock appreciation if profitability and margins improve accordingly.
Mar 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Abg-Wtt Global Life Science Capital Partners Gp Ltd | 1,848,296 | $4M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 982,494 | $2M | New | Mar 2026 |
| 3 | Essex Investment Management Co Llc | 883,931 | $2M | Added | Mar 2026 |
| 4 | Sei Investments Co | 284,816 | $647K | Added | Mar 2026 |
| 5 | Millennium Management | 283,280 | $643K | Added | Mar 2026 |
| 6 | Legato Capital Management Llc | 274,924 | $624K | Added | Mar 2026 |
| 7 | Susquehanna International Group, Llp | 212,114 | $481K | Added | Mar 2026 |
| 8 | Jane Street Group, Llc | 105,301 | $305K | Added | Dec 2025 |
| 9 | Renaissance Technologies Llc | 126,617 | $287K | Added | Mar 2026 |
| 10 | Morgan Stanley | 62,778 | $182K | Added | Dec 2025 |
| 11 | Northern Trust Corp | 48,279 | $110K | Added | Mar 2026 |
| 12 | Nano Cap New Millennium Growth Fund L P | 25,000 | $72K | New | Dec 2025 |
| 13 | Bank Of America Corp /de/ | 31,014 | $70K | Added | Mar 2026 |
| 14 | Algert Global Llc | 23,181 | $53K | New | Mar 2026 |
| 15 | Temasek Holdings (Private) Ltd | 21,818 | $50K | New | Mar 2026 |
| 16 | Barclays Plc | 21,595 | $49K | Reduced | Mar 2026 |
| 17 | Catalyst Funds Management Pty Ltd | 21,200 | $48K | New | Mar 2026 |
| 18 | Qube Research & Technologies Ltd | 15,410 | $35K | Reduced | Mar 2026 |
| 19 | Marshall Wace, Llp | 15,224 | $35K | Reduced | Mar 2026 |
| 20 | Banco Bilbao Vizcaya Argentaria, S.a. | 12,691 | $29K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 16
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 100,365 | $435K | Feb 2026 |
| 2 | iShares Micro-Cap ETF | 79,044 | $179K | Mar 2026 |
| 3 | Fidelity Total Market Index Fund | 31,525 | $137K | Feb 2026 |
| 4 | Fidelity Series Total Market Index Fund | 27,095 | $117K | Feb 2026 |
| 5 | Fidelity Nasdaq Composite Index Fund | 21,522 | $93K | Feb 2026 |
| 6 | Avantis U.S. Small Cap Equity ETF | 16,922 | $73K | Feb 2026 |
| 7 | Dimensional U.S. Targeted Value ETF | 14,653 | $65K | Jan 2026 |
| 8 | U.S. MICRO CAP PORTFOLIO | 8,451 | $37K | Jan 2026 |
| 9 | Dimensional U.S. Core Equity 2 ETF | 5,089 | $23K | Jan 2026 |
| 10 | U.S. CORE EQUITY 2 PORTFOLIO | 2,476 | $11K | Jan 2026 |
| 11 | Victory Extended Market Index Fund | 2,294 | $10K | Jan 2026 |
| 12 | Small Cap Core Fund | 2,924 | $7K | Mar 2026 |
| 13 | U.S. Targeted Value Portfolio | 1,425 | $6K | Jan 2026 |
| 14 | Dimensional US Core Equity 1 ETF | 396 | $2K | Jan 2026 |
| 15 | U.S. Social Core Equity 2 Portfolio | 110 | $487 | Jan 2026 |
| 16 | Guggenheim Active Allocation Fund | 86 | $372 | Feb 2026 |
Valuation
Market Cap
$75.5M
Enterprise Value
$59.8M
P/E (TTM)
-1.52x
Forward P/E
—
PEG Ratio
0.99x
P/B
2.27x
P/S
2.20x
P/FCF
-2.37x
EV/EBITDA
—
Shares Out
44.7M
Financials (TTM)
Revenue
$34.4M
Net Income
-$50.1M
EBITDA
-$45.1M
Free Cash Flow
-$31.9M
Op Cash Flow
-$31.1M
EPS Basic
$-1.05
EPS Diluted
$-1.11
EPS Forward
$-0.92
Gross Margin
12.4%
Op Margin
-144.2%
Net Margin
-145.8%
Balance Sheet
Total Assets
$74.9M
Total Liab.
$41.6M
Total Equity
$33.2M
Cash
$38.3M
LT Debt
$22.6M
Book Value/Sh
$0.74
Debt/Equity
0.72x
Current Ratio
3.31
Quick Ratio
2.36
Returns & Growth
ROE
-141.9%
ROA
-62.9%
ROIC
-82.2%
Rev Growth YoY
+19.7%
EPS Growth YoY
+2.8%
Price Returns
2W
-13.4%
1M
-16.2%
3M
-53.6%
6M
-52.0%
12M
-39.6%
Technicals
52W High
$4.68
52W Low
$1.66
50d MA
$2.14
200d MA
$3.12
RSI (14)
24.50
ATR (14)
$0.12
Beta
1.60
Avg Volume
167K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$8.00
High
$8.00
Low
$8.00
Median
$8.00
Data updated apr 26, 2026 11:28pm
· Source: financialmodelingprep.com